Cancer Biomarkers for Integrative Oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer Biomarkers for Integrative Oncology

Published:2019-03-05 Issue:4 Volume:21 Page:
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Ganguly Aniruddha,Frank David,Kumar Nagi,Cheng Yung-Chi,Chu Edward

Funder

National Institutes of Health

National Cancer Institute

National Center for Complementary and Alternative Medicine

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-019-0782-6.pdf

Reference81 articles.

1. Lam W, Bussom S, Guan F, Jiang Z, Zhang W, Gullen EA, et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med. 2010;2(45):45ra59.

2. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199–225.

3. Kunnumakkara AB, Bordoloi D, Harsha C, Banik K, Gupta SC, Aggarwal BB. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci (Lond). 2017;131(15):1781–99.

4. Samanta SK, Sehrawat A, Kim SH, Hahm ER, Shuai Y, Roy R, et al. Disease subtype-independent biomarkers of breast cancer chemoprevention by the ayurvedic medicine phytochemical withaferin A. J Natl Cancer Inst. 2017;109(6).

5. • Battle TE, Arbiser J, Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005;106(2):690–7 This study defined the molecular mechanism by which a natural product displays a therapeutic index in killing malignant B lymphocytes versus normal lymphocytes. It also showed how honokiol can overcome biologically important resistance mechanisms and synergize with conventional anti-cancer agents, all critical aspects for a novel therapeutic.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical Expression Levels of Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Ki-67 in Canine Cutaneous Squamous Cell Carcinomas;Current Issues in Molecular Biology;2024-05-19

2. A critical assessment of Traditional Chinese Medicine databases as a source for drug discovery;Frontiers in Pharmacology;2024-04-26

3. Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics;Frontiers in Molecular Biosciences;2023-03-28

4. NPCDR: natural product-based drug combination and its disease-specific molecular regulation;Nucleic Acids Research;2021-10-19

5. Pre- and Post-harvest Factors Affecting Glucosinolate Content in Broccoli;Frontiers in Nutrition;2020-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3